🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 65487U108
- Market Cap
- Small Cap
- IPO
- 7/10/2020 · $18.00/share
Business: Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies to treat cancer.
Company Contact
- CEO
- Paul Hastings
- CFO
- Nadir Mahmood
- Headquarters
- 6000 Shoreline Court, Suite 102, South San Francisco, CA 94080
- Phone
- 925-407-1049
- Investor Relations
- Greg Mann · 415-582-4923 · gmann@nkartatx.com